Sustained release tablet of a mixture of alginates and polyacryl

Details Sustained release tablet of a mixture of alginates and polyacryl Sustained release tablet of a mixture of alginates and polyacryl

1992-10-26

1993-07-27

Lee, Lester L.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Tablets, lozenges, or pills

424486, 424487, 424488, A61K 922, A61K 926, A61K 932

Patent

active

052309010

ABSTRACT:
A mixture of an alginate and a polyacrylate in a ratio of from 15:1 to 1:2 is suitable for the preparation of depot drug forms.

REFERENCES:
patent: 4784858 (1988-11-01), Ventouras
1184497, Mar. 26, 1985 Canada.
1566935, May 8, 1980, Great Britain.
Rohm Pharma GmbH, Darmstadt, Germany.
Eudragit.RTM., Eudragit NE 30D and Eudragit L30D, Wassrige Acrylharzdispersionen (2 pages).
Rohm Pharma GmbH, Darmstadt, Germany, Eudragis.RTM. RL 30 D und RS 30 D Anwendung in der Arzneimittelherstellung (pg. 1).
Rohm Pharma GmbH, Darmstadt, Germany, Eudragit.RTM. NE 30 D, Anwending in der Arzneimittelherstellung (pg. 1).
Rohm Pharma GmbH, Darmstadt, Germany, Eudragit.RTM. E fur Schnellzerfallende Filmuberzuge (pg. 1).

Affiliated with

Also associated with

Rating

Sustained release tablet of a mixture of alginates and polyacryl does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sustained release tablet of a mixture of alginates and polyacryl, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained release tablet of a mixture of alginates and polyacryl will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2341080